Recently attending the Veeva R&D and Quality Summit in Madrid, pharmaphorum web editor Nicole Raleigh sat down with Veeva’s president of Europe, Chris Moore. The event seen as a chance to bring the whole industry together, Moore explained how there is an excitement in the industry currently, with more drugs being developed, more conditions being treated – including those not before addressed – and that Veeva is endeavouring to do what it can to help raise the industry capabilities. So it is that the event has become a test bed to see whether the company is on the right track.

In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock is joined by Dr Noura Abul-Husn, VP of genomic health at 23andMe. 

This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one but two back-to-back events in the US. Starting with the American Society of Clinical Oncology’s (ASCO) annual conference in Chicago, before hitting the floor at the BIO International Convention in Boston, there was plenty of innovation, news, and expert knowledge on display.

Fresh from the floor of BIO International, Jonah sat down with pharmaphorum Deep Dive editor Eloise McLennan to reflect on the biggest topics and trends from each event – and the impact these developments may have on pharma over the coming months.

On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul. The company – which has been working in the industry for 13 years now – has most recently been focusing on HCP engagement at a global scale, through use of digital channels.

In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery really is.

Back in March at Reuters Pharma Barcelona, pharmaphorum’s web editor Nicole Raleigh met up with CEO of Within3, Lance Hill. Having met up in Nice in 2022, it was interesting to ‘get up to speed’ a year later.

Discussing how the industry is ‘starved’ of insights – with so much data from so many sources, fragmented, regional, and disconnected, that decisions cannot be reached in the timeframes necessary – Hill defines insights as the epiphany moments; what permit the right actions and determine the trajectory of a therapy.

 In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock connects with Kylie O’Keefe to talk about gene therapy in rare diseases. 

They discuss what different gene therapies have in common and how some particular therapies work. They also talk about what gene therapy means for the industry and for patients, in particularly the paradigm shift of disease-modifying therapies. 

On 21st June, London’s prestigious Royal Society of Medicine will play host to some of the sharpest minds in healthcare as they come together for the inaugural World Without Disease conference, developed by pharmaphorum and the CWWDA.

One of these minds is Daniel Zakowski, CEO of Ready, Set, Food!, who will be taking the stage to discuss why preventing childhood food allergies is an important step in the journey towards the vision of a disease-free world.

Having any chronic health condition is complicated, difficult, and scary. But add in a cultural or social stigma and you create whole new levels of challenge. 

In today’s pharmaphorum podcast, brought to you by Cerner Enviza, an Oracle company, editor in chief Jonah Comstock welcomes Nate Way, senior evidence generation lead at Cerner Enviza and James Geary MBA, MHA, a data analyst who also lives with Cerebral Palsy and anxiety and depression.  

In this latest mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Tommy Bramley, SVP of global consulting at Amerisource Bergen, whilst attending Reuters Pharma Barcelona.